Literature DB >> 16699357

Depression, physical impairment, and treatment of depression in chronic heart failure.

Carolyn L Turvey1, Dawn M Klein, Carla J Pies.   

Abstract

BACKGROUND AND RESEARCH
OBJECTIVE: This study examines the contribution of attitudes about impairment to the relation between depression and physical impairment in patients with heart failure. It also describes the current status of antidepressant treatment in a sample of outpatients with heart failure. SUBJECTS AND METHODS: A total of 32 depressed and 51 nondepressed patients with heart failure were recruited while seeking heart failure treatment in an outpatient heart failure or family practice clinic. Medical, functional, cognitive, and psychological measures were administered at baseline. Depression measures were readministered to the 32 depressed patients at 8, 16, and 24 weeks after the baseline interview. RESULTS AND
CONCLUSIONS: Attitudes about impairment and perceived social support were the strongest cross-sectional correlates of depression. The strong association between physical impairment and depression was no longer significant after controlling for attitudes about impairment. In addition, attitudes about impairment predicted chronicity of depressive symptoms longitudinally after controlling for baseline depressive symptom severity. The relation between physical impairment and depression in heart failure is strongly related to how patients cope with impairment. These results call for the development of additional interventions to treat depression that focus on the emotional adjustment to physical impairment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699357     DOI: 10.1097/00005082-200605000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  8 in total

Review 1.  Can cognitive behaviour therapy be beneficial for heart failure patients?

Authors:  Johan Lundgren; Gerhard Andersson; Peter Johansson
Journal:  Curr Heart Fail Rep       Date:  2015-04

2.  Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure.

Authors:  Rebecca A Gary; Sandra B Dunbar; Melinda K Higgins; Dominique L Musselman; Andrew L Smith
Journal:  J Psychosom Res       Date:  2010-03-12       Impact factor: 3.006

3.  Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs.

Authors:  David B Bekelman; Carolyn T Nowels; Jessica H Retrum; Larry A Allen; Simon Shakar; Evelyn Hutt; Theresa Heyborne; Deborah S Main; Jean S Kutner
Journal:  J Palliat Med       Date:  2011-11-22       Impact factor: 2.947

4.  Anxiety and depression in ethnic minorities with chronic heart failure.

Authors:  Lorraine S Evangelista; Alvina Ter-Galstanyan; Samira Moughrabi; Debra K Moser
Journal:  J Card Fail       Date:  2009-05-21       Impact factor: 5.712

5.  Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain.

Authors:  Misook L Chung; Rebecca L Dekker; Terry A Lennie; Debra K Moser
Journal:  Heart Lung       Date:  2013-01-07       Impact factor: 2.210

6.  A Case Study on Polypharmacy and Depression in a 75-Year-Old Woman with Visual Deficits and Charles Bonnet Syndrome.

Authors:  José Caamaño-Ponte; Martina Gómez Digón; Mercedes Pereira Pía; Antonio de la Iglesia Cabezudo; Margarita Echevarría Canoura; David Facal
Journal:  Geriatrics (Basel)       Date:  2021-12-28

7.  Brief report: Characteristics of antidepressant use in patients with heart failure.

Authors:  Paul J Mills; Joel E Dimsdale; Suzi Hong; Geoffrey Van Den Brande; Laura Redwine; Barry H Greenberg; Thomas Rutledge
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

8.  Patients' perceptions of depression and coronary heart disease: a qualitative UPBEAT-UK study.

Authors:  Rosemary L Simmonds; Andre Tylee; Paul Walters; Diana Rose
Journal:  BMC Fam Pract       Date:  2013-03-19       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.